Family genetic testing can help to diagnose people with rare genetic conditions like Fabry disease, but there still are…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A new infusion protocol that gradually reduces the amount of time needed for the delivery of the Fabry disease…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Enzyme replacement therapy (ERT) may not effectively manage all aspects of Fabry disease in all patients, particularly when started…
Cysts in the kidneys are more common in people with Fabry disease than in other diseases that affect the…
A charitable program can help people with lysosomal storage disorders, such as Fabry disease, who live in underserved communities worldwide…
With data now reaching up to 3.5 years, benefits are continuing to be reported with the use of AVR-RD-01, …
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
Note: This story was updated Sept. 9, 2020, to reflect that PRX-102 is licensed to Chiesi for all markets, including…